Operating Income (Loss) in USD of PULSE BIOSCIENCES, INC. from Q1 2015 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Pulse Biosciences, Inc. quarterly/annual Operating Income (Loss) history and change rate from Q1 2015 to Q3 2025.
  • Pulse Biosciences, Inc. Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$20.4M, a 49.2% decline year-over-year.
  • Pulse Biosciences, Inc. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$78.9M, a 62.7% decline year-over-year.
  • Pulse Biosciences, Inc. annual Operating Income (Loss) for 2024 was -$56.3M, a 29.1% decline from 2023.
  • Pulse Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$43.6M, a 24.9% increase from 2022.
  • Pulse Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$58.1M, a 7.87% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

PULSE BIOSCIENCES, INC. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$78.9M -$20.4M -$6.71M -49.2% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025
Q2 2025 -$72.2M -$20.3M -$8.55M -72.9% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025
Q1 2025 -$63.7M -$18M -$7.43M -70% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025
Q4 2024 -$56.3M -$20.3M -$7.73M -61.7% 01 Oct 2024 31 Dec 2024 10-K 31 Mar 2025
Q3 2024 -$48.5M -$13.7M -$2.4M -21.4% 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025
Q2 2024 -$46.1M -$11.7M -$1.5M -14.7% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025
Q1 2024 -$44.6M -$10.6M -$1.05M -11% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025
Q4 2023 -$43.6M -$12.5M -$3.79M -43.3% 01 Oct 2023 31 Dec 2023 10-K 31 Mar 2025
Q3 2023 -$39.8M -$11.3M +$6.77M +37.6% 01 Jul 2023 30 Sep 2023 10-Q 30 Oct 2024
Q2 2023 -$46.6M -$10.2M +$3.79M +27% 01 Apr 2023 30 Jun 2023 10-Q 19 Aug 2024
Q1 2023 -$50.3M -$9.56M +$7.71M +44.6% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024
Q4 2022 -$58.1M -$8.75M +$6.67M +43.3% 01 Oct 2022 31 Dec 2022 10-K 28 Mar 2024
Q3 2022 -$64.7M -$18M -$3.75M -26.3% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023
Q2 2022 -$61M -$14M +$792K +5.35% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023
Q1 2022 -$61.8M -$17.3M +$1.25M +6.76% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 -$63M -$15.4M 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2023
Q3 2021 -$14.3M -$1.37M -10.6% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 -$14.8M 01 Apr 2021 30 Jun 2021 10-Q 10 Aug 2022
Q1 2021 -$18.5M 01 Jan 2021 31 Mar 2021 10-Q 11 May 2022
Q3 2020 -$12.9M -$1.16M -9.87% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021
Q4 2019 -$47M -$13.8M -$4.84M -54% 01 Oct 2019 31 Dec 2019 10-K 16 Mar 2020
Q3 2019 -$42.1M -$11.7M -$985K -9.15% 01 Jul 2019 30 Sep 2019 10-K 16 Mar 2020
Q2 2019 -$41.2M -$11.4M -$2.2M -24% 01 Apr 2019 30 Jun 2019 10-K 16 Mar 2020
Q1 2019 -$39M -$10.1M -$1.41M -16.3% 01 Jan 2019 31 Mar 2019 10-K 16 Mar 2020
Q4 2018 -$37.5M -$8.95M -$250K -2.87% 01 Oct 2018 31 Dec 2018 10-K 16 Mar 2020
Q3 2018 -$37.3M -$10.8M -$3.28M -43.7% 01 Jul 2018 30 Sep 2018 10-K 16 Mar 2020
Q2 2018 -$34M -$9.16M -$2.98M -48.3% 01 Apr 2018 30 Jun 2018 10-K 16 Mar 2020
Q1 2018 -$31M -$8.67M -$5.47M -171% 01 Jan 2018 31 Mar 2018 10-K 16 Mar 2020
Q4 2017 -$25.6M -$8.7M -$5.89M -210% 01 Oct 2017 31 Dec 2017 10-K 14 Mar 2019
Q3 2017 -$19.7M -$7.49M -$4.72M -171% 01 Jul 2017 30 Sep 2017 10-K 14 Mar 2019
Q2 2017 -$15M -$6.18M -$3.92M -174% 01 Apr 2017 30 Jun 2017 10-K 14 Mar 2019
Q1 2017 -$11M -$3.2M -$1.51M -89.9% 01 Jan 2017 31 Mar 2017 10-K 14 Mar 2019
Q4 2016 -$9.52M -$2.81M -$1.27M -83% 01 Oct 2016 31 Dec 2016 10-K 16 Mar 2018
Q3 2016 -$8.24M -$2.77M -$1.53M -124% 01 Jul 2016 30 Sep 2016 10-K 16 Mar 2018
Q2 2016 -$6.71M -$2.26M -$1.3M -136% 01 Apr 2016 30 Jun 2016 10-K 16 Mar 2018
Q1 2016 -$5.41M -$1.68M -$941K -127% 01 Jan 2016 31 Mar 2016 10-K 16 Mar 2018
Q4 2015 -$4.47M -$1.54M 01 Oct 2015 31 Dec 2015 10-K 20 Mar 2017
Q3 2015 -$1.23M 01 Jul 2015 30 Sep 2015 10-K 20 Mar 2017
Q2 2015 -$956K 01 Apr 2015 30 Jun 2015 10-K 20 Mar 2017
Q1 2015 -$743K 01 Jan 2015 31 Mar 2015 10-K 20 Mar 2017

PULSE BIOSCIENCES, INC. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$56.3M -$12.7M -29.1% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025
2023 -$43.6M +$14.5M +24.9% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025
2022 -$58.1M +$4.96M +7.87% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024
2021 -$63M -$13M -26.1% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023
2020 -$50M -$2.01M -4.19% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2023
2019 -$48M -$10.4M -27.7% 01 Jan 2019 31 Dec 2019 10-K 31 Mar 2022
2018 -$37.5M -$12M -46.8% 01 Jan 2018 31 Dec 2018 10-K 12 Mar 2021
2017 -$25.6M -$16M -169% 01 Jan 2017 31 Dec 2017 10-K 16 Mar 2020
2016 -$9.52M -$5.05M -113% 01 Jan 2016 31 Dec 2016 10-K 14 Mar 2019
2015 -$4.47M 01 Jan 2015 31 Dec 2015 10-K 16 Mar 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.